Literature DB >> 27655287

Gamma-synuclein binds to AKT and promotes cancer cell survival and proliferation.

Zengxia Ma1,2, Jianyi Niu3, Erlian Sun1, Xuedong Rong2, Xianxin Zhang2, Yuanrong Ju4.   

Abstract

Hyperactivation of AKT plays a critical role in the survival and proliferation of cancer cells. However, the molecular mechanisms underlying AKT activation remain elusive. Here, we tested the effect of γ-synuclein, a member of the synuclein family of proteins, on the activation of AKT. We show that the expression level of γ-synuclein is increased in non-small cell lung cancer (NSCLC) tissues. γ-Synuclein binds to the protein kinase domain of AKT and promotes its phosphorylation. Overexpression of γ-synuclein in H157 cells enhances cell proliferation and protects the cells from staurosporine-induced cytotoxicity. Knockdown of γ-synuclein attenuates AKT activation and cell proliferation induced by epidermal growth factor. The effect of γ-synuclein is abolished when AKT is depleted. Thus, γ-synuclein promotes cell survival and proliferation via activating AKT and may play a causal role in the pathogenesis of NSCLC.

Entities:  

Keywords:  AKT; H157 cells; Non-small cell lung cancer; γ-Synuclein

Mesh:

Substances:

Year:  2016        PMID: 27655287     DOI: 10.1007/s13277-016-5371-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  39 in total

1.  Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.

Authors:  J Brognard; A S Clark; Y Ni; P A Dennis
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

Review 2.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

3.  Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing.

Authors:  H Ji; Y E Liu; T Jia; M Wang; J Liu; G Xiao; B K Joseph; C Rosen; Y E Shi
Journal:  Cancer Res       Date:  1997-02-15       Impact factor: 12.701

4.  An EGFR/PI3K/AKT axis promotes accumulation of the Rac1-GEF Tiam1 that is critical in EGFR-driven tumorigenesis.

Authors:  G Zhu; Z Fan; M Ding; H Zhang; L Mu; Y Ding; Y Zhang; B Jia; L Chen; Z Chang; W Wu
Journal:  Oncogene       Date:  2015-03-09       Impact factor: 9.867

5.  Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions.

Authors:  Binaifer R Balsara; Jianming Pei; Yasuhiro Mitsuuchi; Robert Page; Andres Klein-Szanto; Hao Wang; Michael Unger; Joseph R Testa
Journal:  Carcinogenesis       Date:  2004-07-07       Impact factor: 4.944

Review 6.  Ligand-Independent EGFR Signaling.

Authors:  Gao Guo; Ke Gong; Bryan Wohlfeld; Kimmo J Hatanpaa; Dawen Zhao; Amyn A Habib
Journal:  Cancer Res       Date:  2015-08-17       Impact factor: 12.701

7.  Stimulation of breast cancer invasion and metastasis by synuclein gamma.

Authors:  T Jia; Y E Liu; J Liu; Y E Shi
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

8.  Stimulation of estrogen receptor signaling by gamma synuclein.

Authors:  Yangfu Jiang; Yiliang Ellie Liu; AiPing Lu; Anu Gupta; Itzhak D Goldberg; Jingwen Liu; Y Eric Shi
Journal:  Cancer Res       Date:  2003-07-15       Impact factor: 12.701

9.  Lung cancer.

Authors:  W D Travis; L B Travis; S S Devesa
Journal:  Cancer       Date:  1995-01-01       Impact factor: 6.860

10.  Lung Cancer: Are we up to the Challenge?

Authors:  Luca Esposito; Daniele Conti; Ramyasri Ailavajhala; Nansie Khalil; Antonio Giordano
Journal:  Curr Genomics       Date:  2010-11       Impact factor: 2.236

View more
  4 in total

1.  Hexokinase 2 discerns a novel circulating tumor cell population associated with poor prognosis in lung cancer patients.

Authors:  Liu Yang; Xiaowei Yan; Jie Chen; Qiong Zhan; Yingqi Hua; Shili Xu; Ziming Li; Zhuo Wang; Yu Dong; Dongqing Zuo; Min Xue; Yin Tang; Harvey R Herschman; Shun Lu; Qihui Shi; Wei Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-16       Impact factor: 11.205

2.  Curcumin induces re‑expression of BRCA1 and suppression of γ synuclein by modulating DNA promoter methylation in breast cancer cell lines.

Authors:  Nujoud Al-Yousef; Zakia Shinwari; Bushra Al-Shahrani; Maram Al-Showimi; Nisreen Al-Moghrabi
Journal:  Oncol Rep       Date:  2020-01-20       Impact factor: 3.906

3.  Upregulation of Synuclein-γ and Snai1 Contributes to Poor Clinical Prognosis in Oral Squamous Cell Carcinoma Patients.

Authors:  Jie Yang; Yangyang Pan; Lu Peng; Licui Zhang; Juan Zhao; Zhihong Zheng; Jun Zheng; Xiaoli Xu; Yan Zeng
Journal:  Biomed Res Int       Date:  2022-04-07       Impact factor: 3.246

4.  Synuclein gamma expression enhances radiation resistance of breast cancer cells.

Authors:  Lu Tian; Yucui Zhao; Marie-José Truong; Chann Lagadec; Roland P Bourette
Journal:  Oncotarget       Date:  2018-06-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.